UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

Zajicek, JP; Sanders, HP; Wright, DE; Vickery, PJ; Ingram, WM; Reilly, SM; ... Thompson, AJ; + view all (2005) Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry , 76 (12) 1664 - 1669. 10.1136/jnnp.2005.070136.

Full text not available from this repository.

Abstract

To test the effectiveness and long term safety of cannabinoids in multiple sclerosis (MS), in a follow up to the main Cannabinoids in Multiple Sclerosis (CAMS) study.

Type:Article
Title:Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
Location:England
DOI:10.1136/jnnp.2005.070136
Language:English
Keywords:Administration, Oral, Adolescent, Adult, Analgesics, Non-Narcotic, Cannabis, Disabled Persons, Double-Blind Method, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Placebos, Plant Extracts, Severity of Illness Index, Treatment Outcome
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > MRC Clinical Trials Unit at UCL

Archive Staff Only: edit this record